EPAC also inhibits the pro-apoptotic activity of PKA in acute lymphoblastic leukemia (ALL) cells [129] by first activating Rap1 and H-Ras, which in turn, boosts the stimulation of ERK1/2 and Akt (Figure 5B) [128]. Here, MAPK3 is linked to acute lymphoblastic leukemia.